Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma

Hematol Oncol Stem Cell Ther. 2016 Mar;9(1):26-9. doi: 10.1016/j.hemonc.2015.06.007. Epub 2015 Jul 8.

Abstract

Plasmacytomas could involve any organ, and at times might pose a diagnostic challenge when the site of involvement is unusual, or if the presentation is similar to other diseases. We describe a 48-year-old man presenting with worsening shortness of breath and chest discomfort with radiologic evidence of mediastinal enlargement, mimicking a lymphoma with mediastinal involvement. An excisional biopsy of a mediastinal lymph node showed a plasma-cell infiltrate strongly positive for CD138, with a flow-cytometry analysis showing a population of lambda-restricted neoplastic plasma cells. He failed to respond to 50Gy involved-field radiotherapy, but achieved a partial response to combination chemotherapy. He underwent high-dose chemotherapy with melphalan (200mg/m(2)) followed by lenalidomide maintenance, and is in complete remission 18months postautografting. This case illustrates a unique and rare presentation of primary lymph-node plasmacytomas involving the mediastinum potentially mistaken as lymphoid malignancy. Clinicians should be aware of the plasma-cell origin of the mediastinal neoplastic process.

Keywords: Mediastinal involvement; Primary plasmacytoma.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Humans
  • Lenalidomide
  • Lymph Nodes / drug effects
  • Lymph Nodes / pathology*
  • Lymph Nodes / radiation effects
  • Male
  • Mediastinal Neoplasms / diagnosis
  • Mediastinal Neoplasms / drug therapy
  • Mediastinal Neoplasms / pathology*
  • Mediastinal Neoplasms / radiotherapy
  • Mediastinum / pathology*
  • Mediastinum / radiation effects
  • Melphalan / therapeutic use
  • Middle Aged
  • Plasma Cells / drug effects
  • Plasma Cells / pathology*
  • Plasma Cells / radiation effects
  • Plasmacytoma / diagnosis
  • Plasmacytoma / drug therapy
  • Plasmacytoma / pathology*
  • Plasmacytoma / radiotherapy
  • Syndecan-1 / analysis
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Alkylating
  • Syndecan-1
  • Thalidomide
  • Lenalidomide
  • Melphalan